MFDS — authorised 16 July 2021
- Marketing authorisation holder: SANOFI
- Status: likely_approved
🇰🇷 Fexinidazole in South Korea
MFDS authorised Fexinidazole on 16 July 2021
Marketing authorisation
Fexinidazole in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Fexinidazole approved in South Korea?
Yes. MFDS authorised it on 16 July 2021.
Who is the marketing authorisation holder for Fexinidazole in South Korea?
SANOFI holds the South Korean marketing authorisation.